Michel R. Nasr

Dr. Michel R. Nasr


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2006 in Laboratory Investigation
Verified
Journal Article
Open access
PDF file
MNMichel R. Nasr
Michel R. Nasr
SMSanjay Mukhopadhyay
Sanjay Mukhopadhyay
SZShengle Zhang
Shengle Zhang
AKAnna-Luise A Katzenstein
Anna-Luise A Katzenstein
Papillary thyroid carcinoma and its variants can be difficult to distinguish from cellular adenomatous nodules. Prior studies have advocated various antibodies to aid in the differential diagnosis, but there is little agreement on their utility. We undertook this study to evaluate immunohistochemical markers in the diagnosis and differential diagnosis of papillary thyroid carcinoma. Ten cases of papillary thyroid carcinoma were initially stained for HBME1, CK19, fibronectin1, Ki-67, Calretinin, p16, SFTPB and CITED1. Additionally, two previously untested antibodies to molecules that have been found to be upregulated in papillary thyroid carcinoma (CST6 and EPS8) were also evaluated. Of these, only HBME1, CK19 and fibronectin1 showed diagnostic utility. These three markers were then further evaluated in 51 papillary thyroid carcinomas and 57 benign thyroids. HBME1 was the most sensitive and specific marker, staining 49/51 papillary thyroid carcinomas and only 4/57 benign thyroids. CK19 was equally sensitive staining all 51 papillary thyroid carcinomas, but it was nonspecific staining 39 of 57 benign thyroids. A negative result, however, was helpful in excluding papillary thyroid carcinoma. Fibronectin1 was positive in 35/51 papillary thyroid carcinomas (69%) and 4/57 (7%) benign thyroids, but its utility was hampered by high background staining. These findings suggest that the combination of HBME1 and CK19 has the greatest diagnostic utility in the differentiation of papillary thyroid carcinoma from its benign mimics.

1 March 2006 in Archives of Environmental & Occupational Health
Verified
Journal Article
Closed access
MNMichel R. Nasr
Michel R. Nasr
DSD. Savici
D. Savici
LTL. Tudor
L. Tudor
DAD. Abou Abdallah
D. Abou Abdallah
NNN. Newman
N. Newman
PDPh D
Ph D
Smoking is alleged to cause pulmonary fibrosis, but the role of inorganic dust particulates has not been adequately examined. The authors hypothesize that inorganic dust exposure is an independent risk factor for the development of fibrosis in smokers. They studied a prospective series of 34 subjects with open lung biopsies, 18 of whom had adequate lung parenchyma for evaluation. They also examined the relationships between smoking (pack-years), respiratory bronchiolitis (RB), inorganic dusts, and interstitial fibrosis. They graded RB, fibrosis, and particulate dust by means of light microscopy. They performed a semiquantitative analysis of dust burden by using scanning electron microscopy with energy-dispersive X-ray spectroscopy. A logistic regression analysis demonstrated a significant association between smoking and RB (p = .03), but not between smoking and fibrosis or between RB and fibrosis. Fibrosis was significantly associated with silica (pp = .004) and titanium (pp = .0006) concentrations. The r...

1 November 2019 in Immunobiology
Verified
Journal Article
Closed access
CEChidalu Edechi
Chidalu Edechi
MNMichel R. Nasr
Michel R. Nasr
AKAlgernon Karim
Algernon Karim
ABAnne Blanchard
Anne Blanchard
CECynthia A. Ellison
Cynthia A. Ellison
YMYvonne Myal
Yvonne Myal